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synthetase (PurM), from the Escherichia coli purine biosynthetic
pathway at 2.5 Å resolution
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and Steven E Ealick1*
Background: The purine biosynthetic pathway in procaryotes enlists eleven
enzymes, six of which use ATP. Enzymes 5 and 6 of this pathway,
formylglycinamide ribonucleotide (FGAR) amidotransferase (PurL) and
aminoimidazole ribonucleotide (AIR) synthetase (PurM) utilize ATP to activate
the oxygen of an amide within their substrate toward nucleophilic attack by a
nitrogen. AIR synthetase uses the product of PurL, formylglycinamidine
ribonucleotide (FGAM) and ATP to make AIR, ADP and Pi.
Results: The structure of a hexahistidine-tagged PurM has been solved by
multiwavelength anomalous diffraction phasing techniques using protein
containing 28 selenomethionines per asymmetric unit. The final model of PurM
consists of two crystallographically independent dimers and four sulfates. The
overall R factor at 2.5 Å resolution is 19.2%, with an Rfree of 26.4%. The active
site, identified in part by conserved residues, is proposed to be a long groove
generated by the interaction of two monomers. A search of the sequence
databases suggests that the ATP-binding sites between PurM and PurL may be
structurally conserved.
Conclusions: The first structure of a new class of ATP-binding enzyme, PurM,
has been solved and a model for the active site has been proposed. The
structure is unprecedented, with an extensive and unusual sheet-mediated
intersubunit interaction defining the active-site grooves. Sequence searches
suggest that two successive enzymes in the purine biosynthetic pathway,
proposed to use similar chemistries, will have similar ATP-binding domains.
Introduction
The purine biosynthetic pathway serves as an excellent
paradigm for thinking about the evolution of a biosynthetic
pathway, including the importance of conserved strategies
for substrate binding and/or chemical reactivity in this
process. Each enzyme in this pathway binds 1′-substituted
ribose 5-phosphate derivatives [1]. Six of twelve enzymes
require ATP as a dehydrating agent, and four of these six
enzymes are proposed to involve phosphoanhydride inter-
mediates (PurD [GAR synthetase; EC 6.3.4.13], PurT
[GAR transformylase, formate-dependent; EC 6.3.4.-],
PurK [N5-carboxyaminoimidazole ribonucleotide syn-
thetase; EC 6.3.4.-], and PurC [4-[N-succinocarboxamide]-
5-aminoimidazole ribonucleotide synthetase; EC 6.3.2.6]).
The structures of PurD, PurK, and PurC that have recently
become available demonstrate that PurD [2] and PurK [3]
are part of the ATP grasp superfamily [4–8], while PurC
has a related but distinct ATP-binding motif [9]. The high
degree of sequence homology between PurT and PurK
guarantees that the former is also part of the ATP grasp
superfamily [10,11]. The relationship of PurD to PurK and
PurT is of evolutionary interest as the latter two enzymes
seem to be missing from avian and mammalian systems.
The possibility that PurK and PurT have evolved from
PurD has been the subject of recent discussion [3]. 
The two additional ATP-requiring enzymes in this
pathway are formylglycinamide ribonucleotide (FGAM)
synthetase (PurL) and aminoimidazole ribonucleotide
(AIR) synthetase (PurM). PurL catalyzes the conversion
of formylglycinamide ribonucleotide (FGAR), ATP and
glutamine to FGAM, glutamate, ADP and Pi. PurM cat-
alyzes the conversion of FGAM and ATP to AIR, ADP,
and Pi. Both enzymes utilize very similar substrates and
are proposed to utilize very similar chemistry (Figure 1). 
In both cases ATP is proposed to phosphorylate an amide
oxygen, generating an intermediate activated for nucle-
ophilic attack [12,13]. PurL uses NH3 derived from gluta-
mine as the nucleophile, whereas PurM utilizes the N-1 of
FGAM to catalyze an intramolecular ring formation. Iter-
ated PSI-BLAST searches of sequence databases [14]
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using E. coli PurM as a query sequence reveal some very
interesting hits. Notably, the searches show that those
forms of PurL that have an independent glutamine-
binding protein (designated PurQ) seem to have sequence
homology with all forms of PurM in the putative
ATP-metal-binding domain, as well as in the putative sub-
strate-nucleotide-binding domain. An intriguing and
unsolved question is the relationship between these two
enzymatic activities and their structures. Toward under-
standing this relationship, we now report the first structure
of an enzyme, E. coli PurM, catalyzing this reaction type. 
The structure of E. coli PurM is thus far unprecedented.
Although the protein is not bound to any organic ligand, it
contains a sulfate from crystallization conditions that is
proposed to reside in the FGAM-binding domain.
Sequence conservation of 23 residues among 24 available
PurM sequences and recent ATP affinity labeling experi-
ments allow us to identify the active-site region and to
speculate on both the ATP- and FGAM-binding sites.
PurM catalyzes reaction six of the purine pathway
(Figure 1). The proteins from E. coli, avian, and mam-
malian sources have been best characterized to date. The
E. coli enzyme is a dimer with identical subunits
(Md = 38 kDa). Mechanistic studies have shown that the
oxygen of 18O-labeled formamide is transferred to Pi [12],
consistent with the mechanism shown in Figure 1. In
addition, studies of prochirally labelled FGAM suggest
that either proton can be removed to form the aroma-
tized aminoimidazole ring of the ribonucleotide [15].
These results suggest that this step happens non-enzy-
matically. Efforts to determine if a phosphorylated
enzyme intermediate, in addition to a phosphorylated
substrate intermediate, is involved in this reaction have
been thus far unsuccessful [16].
In addition to its unusual reaction chemistry, PurM has
attracted attention because it is a component of the mam-
malian trifunctional protein containing glycinamide
ribonucleotide (GAR) synthetase (PurD, activity 2) and
GAR transformylase (PurN, activity 3) [17]. The latter
enzyme has been the target of the antifolates 5-deazacy-
clotetrahydrofolate [18] and N-[4-[2-2(amino-3,4-dihydro-
4-oxo-7H-pyrrolo [2,3-d]pyrimidin-5-yl)ethyl]-benzoyl]-L-
glutamic acid, each of which has anti-tumour activity [19].
In fact, PurM has been found in several multifunctional
proteins within different sequence contexts (Figure 2).
The recent structure of PurD [2], the availability of the
structure of PurN [20], and the structure presented herein
allow us to speculate on the structure of the mammalian
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Figure 1
Reactions catalyzed by (a) PurL and 
(b) PurM. Both are proposed to generate a
phosphorylated intermediate (R is
ribose 5-phosphate).
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trifunctional protein. The first detailed structure of a
PurM and a model for the trifunctional protein are the
subject of this report. This structure provides a starting
point for thinking about the unusual chemistry of this
reaction and the structural relationship of PurL to PurM.
Results and discussion
Purification and crystallization
(His)6-tagged PurM from E. coli was purified using a one-
step nickel column affinity procedure, yielding 21 mg of
95% homogeneous protein from a 1.2 l culture. The
enzyme was active in both wild-type and selenomethion-
ine-substituted forms, with specific activities of 6.7 and
1.4 U/mg, respectively, at 37°C. These values are compa-
rable to the 3.9 U/mg wild-type PurM activity determined
using enzyme purified by ATP-affinity chromatography
[12]. The substitution of methionine by selenomethionine
(SeMet), required for the structure solution (see below),
lowers the activity of (His)6-tagged PurM to 0.9 s–1. The
solution aggregation state of (His)6-tagged PurM was
found to be a mixture of dimers and tetramers using a
BioSilect size-exclusion column at room temperature. The
molar ratio of dimer:tetramer is approximately 6:1 (data
not shown). A comparable distribution of species was
observed for the SeMet-substituted His-tagged PurM by
Sephacryl 300HR size-exclusion column chromatography
at 4°C (data not shown). These results contrast to those
observed with the wild-type E. coli PurM, which behaves
as a dimer in solution. The difference in aggregation state
may therefore result from the (His)6 tag. As none of the
N-terminal (His)6-tag residues are detectable by crystal-
lography, it is not possible to determine the structural
basis for the different aggregation states. Sequence align-
ments reveal that E. coli PurM has 2–6 additional N-termi-
nal residues compared to most other bacterial PurMs,
which in turn suggests that the disordered residues of the
(His)6 tag and first four amino acids of the protein crystal-
lized here are not important in catalysis. PurM crystallizes
from ammonium sulfate in space group P212121 with unit
cell dimensions of a = 71.2 Å, b = 211.7 Å, and c = 94.4 Å.
Each asymmetric unit contains four monomers; however,
the PurM dimer is the biologically active form [12].
Structure determination and refinement
The structure of PurM was determined by multiwave-
length anomalous diffraction (MAD) phasing techniques
using SeMet-incorporated protein. The crystallographic
asymmetric unit contains two dimers, which corresponds to
28 Se-atoms. The Se atom positions were located using the
computer program SnB [21], which utilizes direct methods
based on Hauptman’s minimal function [22]. E values
derived from the anomalous-scattering signal correspond-
ing to the peak wavelength alone were the most effective
in locating the Se atoms. As described in the Materials and
methods section, 23 of 28 Se-atom positions were located
using anomalous differences to 3.0 Å resolution. The
results we report here along with several other recent
results [23] illustrate that MAD-phasing methods can be
effectively applied to large structures.
The final model of PurM consists of two crystallographi-
cally independent dimers, 538 water molecules, and four
sulfate ions. Dimer 1 contains residues 5–345 for monomer
A and 21–345 for monomer B and dimer 2 contains
residues 21–345 for each monomer A and B. The overall R
factor at 2.5 Å resolution is 19.2% (Rfree 26.4%). Examina-
tion of the final model using PROCHECK [24] suggests
that the model is of very high quality. 
Structure of the monomer
The PurM monomer consists of 345 amino acid residues
in a single chain that can be divided into two clear struc-
tural domains. Domain A includes residues 16–166 and
domain B includes residues 178–345. The two domains
are connected by an 11-residue, well-defined loop from
residue 167 to 177. The overall fold of PurM is illustrated
in Figure 3. 
Both domain A and domain B have an α/β-type fold. The
N-terminal domain A is 47% α helix, 28% β sheet and 25%
loops. The first 16 residues of domain A include the poly-
histidine tag used for purification and are disordered.
Domain A contains a four-stranded mixed β sheet ordered
as β1β4β2β3. Strands β1, β2 and β3 are parallel to each
other while strand β4 is antiparallel to the other three. All
four β strands are unusually long, having 10–11 residues
each. The sheet is flanked on one side by four α helices
while the other side of the sheet forms the dimer inter-
face. Three of the helices are long, with about 20 residues,
while the shorter α2 is only half as long as the others.
Domain A contains a long, poorly ordered glycine-rich
loop between helix α1 and strand β1. This loop contains
residues 40–46 (GGLGGFG), which have comparatively
high temperature factors.
The C-terminal domain B is 36% α helix, 28% β sheet,
and 46% loops. Both the α helices and the β strands in
domain B are shorter than those in domain A. Domain B
contains a six-stranded mixed β sheet ordered as
β6β8β5β9β7β10. All six β strands are seven to nine
residues long. The first five strands form an antiparallel
sheet with the final strand, β10, parallel to β7. Seven α
helices flank the β sheet, with α7 and α11 on one side of
the sheet, α8 on the other side of the sheet and α5, α6, α9
and α10 clustered along one edge of the sheet. Helices
α5–α10 are about 9–11 residues long while α11 is a little
longer, with 13 residues.
The two domains are connected by a hinge-like loop con-
sisting of 11 residues (red trace in Figure 3a). All of the
residues in the loop region (S167EIIDGSKVSD177) are well
ordered. Helix α3 of domain A interacts strongly with
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helices α6 and α7 of domain B and helix α2 of domain A
interacts with helices α5 and α6 of domain B.
PurM displays a novel fold
DALI database searches [25] using the whole monomer or
domains A and B separately reveal no topologically similar
protein structure, indicating a novel protein fold. Further-
more, no ATP-binding protein could be identified with
structural features similar to PurM, suggesting that PurM
contains a novel ATP-binding domain. 
Structure of the dimer 
The PurM dimer is formed from identical monomers
related by a noncrystallographic twofold axis with the N
and C termini of different subunits about 20–25 Å apart.
The monomeric subunit is about 55 Å long, 30 Å wide and
15 Å thick on the domain-A side and 25 Å thick on the
domain-B side. The dimer is shaped like a prolate ellip-
soid with two prominent grooves on opposite sides
(Figure 4). These grooves, or clefts, are defined by por-
tions of each monomer. The overall dimensions of the
dimer are about 85 × 45 × 60 Å.
The dimer interface is formed by joining two four-
stranded β sheets face to face, one from each subunit,
resulting in an eight-stranded β-barrel-like structure
flanked by eight α helices (Figure 4). Most of the back-
bone distances between the two sheets are in the range of
6–7 Å and the intersubunit interactions are mostly
hydrophobic. Essentially all of the dimer contacts occur
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Figure 3
Structure of the PurM monomer. (a) Ribbon
diagram showing key structural features.
Helices are shown in blue and strands in
green. Domain A is outlined in gold and
domain B is outlined in silver. (b) Topology
diagram. Secondary structural elements are
labeled with the first and last amino acid
sequence number. (c) Stereoview of the Cα
backbone. Every tenth Cα position is labeled.
Domain A is shown in gold and domain B is
shown in silver.
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between domain A of one subunit and domain A of a
twofold-related subunit. Thus, PurM displays a core made
from two copies of domain A, resulting in a four-layer
αββα sandwich. The core structure has a length of about
50 Å along the barrel axis and about 35 Å in the direction
perpendicular to the barrel axis. Two copies of domain B
are attached to opposite ends of the core structure using a
single connecting loop for each (Figure 4).
Proposed active site
Attempts to soak AIR, ADP or ATP into the crystals have
thus far been unsuccessful, resulting in either damaged
crystals or no bound ligand. In addition, attempts to
co-crystallize PurM with products or reactants have not
yet succeeded. For these reasons, other methods were
sought to identify the active site. Three pieces of evi-
dence support the proposal that the active site of PurM is
located within a large cleft formed primarily from β1, α2
and α3 of domain A, α5 and β6 of domain B from one
monomer and β3 of the domain A of the second monomer
(Figure 5). The cleft is about 30 Å long, about 15 Å wide
and about 7 Å deep, about the right size and shape to
contain the mononucleotide substrate, FGAM, and an
extended ATP molecule with its terminal phosphate posi-
tioned adjacent to the mononucleotide-binding site.
First, an alignment of 23 PurM sequences indicates that
most of the conserved residues line the putative active-site
cleft. Second, the sulfate that co-crystallizes with PurM is
buried at one end of the cleft. This site, as discussed below,
is proposed to represent the mononucleotide-binding site.
Third, affinity-labeling studies with fluorosulfonylbenzoy-
ladenosine (FSBA), an ATP analog, acylated K27, which is
located at the other end of the cleft from the sulfate-
binding site [26]. The labeling by FSBA was potentiated
by the presence of FGAM and inhibited by the presence of
ADP, suggesting that this end of the cleft binds ATP. 
Sequence alignments
An alignment of nine PurMs showing the greatest sequence
diversity, but excluding the extreme thermophiles, is
shown in Figure 6. The locations of the conserved residues
are shown in Figures 5a and b. Most striking is the align-
ment of 19 glycines. All of the sequences shown contain a
glycine-rich loop located between residues 40 and 47
(GGLGGFGA [single-letter amino acid code] in E. coli).
G43 and F45 are completely conserved in mesophiles; this
region has a different sequence in extreme thermophiles, a
modification that may reduce its flexibility at elevated tem-
peratures. This loop exists in multiple conformations
(Figure 5a) and is at the end of the cleft near the K27 that
was labeled with FSBA. A second glycine-rich region
including G66VGxK70 (where x is any amino acid) near the
beginning of α2 is also conserved, as is the glycine-rich
region at the beginning of α5 (S186xGxHSNGxxL196).
These last two regions, as described below, form the
sulfate-binding site. Finally, a number of conserved polar
residues reside in the putative active-site cleft: D94, H247,
R259, T249 (Figure 5a). These residues are potential candi-
dates for metal-ion ligands and for general acid and base
catalysts. D86, D155 and H190 are also conserved.
Two other conserved residues adopt unusual buried con-
formations near the cleft: D107 is buried in a hydrophobic
pocket (and is presumably protonated) in the central core
defined by the A domains. K70 extends away from the
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Figure 4
Structure of the PurM dimer. Ribbon diagram viewed down the twofold
axis. Major structural features and the strands of the central β barrel,
which form most of the dimer interface, are labeled. For subunit 1, the
domain-A ribbon is highlighted in gold, the domain-B ribbon is
highlighted in silver and the linker is shown in red. For subunit 2, the
ribbon is highlighted in light blue.
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groove through the interface between each subunit’s A
and B domains to make a hydrogen bond with the back-
bone oxygen of A224. K70 is part of a group of buried, con-
served residues underneath the sulfate-binding site that
may contribute to defining its structure (see below).
Sulfate-binding site
A sulfate ion is bound near the N-terminal end of helix α2
from domain A and the N-terminal end of helix α5 from
domain B (Figure 3a and Figure 5a). In one of the two
monomers, residues 5–20 extend across the groove and coil
over the sulfate-binding site (Figure 5). Residues 5–11 are
bound in a small groove on the B domain of the partner
subunit. Hydrogen bonds are formed between the sulfate
and the amide groups of Thr69 and Gly193 and with the
sidechain and/or amide group of Ser195. The reaction cat-
alyzed by PurM (Figure 1) suggests that this sulfate-
binding site could represent either a site for ATP binding,
for the product Pi binding, or for mononucleotide binding.
As the sulfate site is deeply buried and consequently inac-
cessible to interaction with a mononucleotide, it is unlikely
that this site represents one of the phosphate groups of
ATP. It is also unlikely that this is the binding site of the Pi
produced during the reaction, for the same reason. In addi-
tion, as noted above, affinity labeling with an ATP analog
suggests that ATP binds at the other end of the cleft, near
the glycine-rich loop (Figure 5). Thus, it seems more likely
that the sulfate occupies the phosphate-binding site of the
nucleotide reactant (FGAM) and product (AIR). However,
if this is in fact the case, then it differs from the mononu-
cleotide-binding site in other enzymes involved in the
purine biosynthetic pathway. PurF, PurD, PurN, PurK,
PurE, and PurC all seem to bind the phosphate of the
common ribose-5-P moiety at a loop between a β strand
and an α helix [2,3,20,27]. In PurM, the sulfate/phosphate-
binding site is located at the N-terminal ends of two
helices, one each from domain A and domain B. 
Proposed ATP-binding motif
On the basis of FSBA labeling and the sequence conser-
vation of the glycine-rich loop, we propose that the ATP-
binding region is between this loop, which extends into
the active-site cleft, and the central core of the protein,
defined by the two A domains [26]. The flexibility of this
region of the molecule, which is typical of ATP-binding
loops that close over chemically reactive intermediates
(e.g., the ATP grasp motif [28]), is consistent with rela-
tively high temperature factors and the observed confor-
mational differences between the glycine-rich loop in
monomers 1 and 2. An important requirement for the
ATP-binding site is conserved residues that could ligate
Mg2+ ions, which are absolutely required for E. coli and
chicken PurM activity [12]. Asp65, Asp94, and Glu141 are
all positioned near the tip of the glycine-rich loop, where
any or all of them could be involved in Mg2+ binding
when ATP binds at the gap between the glycine-rich loop
and the central core of PurM (Figure 5a). K+ is also
required for PurM activity [12], but it is not known if the
ion participates in ATP binding.
As conserved residues from both subunits are positioned
in this putative active-site groove, a dimer seems to be
the minimal functional unit of PurM. This should also be
true of other forms of PurM (Figure 2). The fly
PurD–PurM–PurM′–PurN fusion protein could be a
dimer in solution, but because it contains an internal
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Figure 5
Proposed active site for PurM. (a) Ribbon diagram of the active-site
region. Conserved residues, shown in ball-and-stick representation, are
labeled. Portions of domain A from one subunit are shown in blue. For
the other subunit (labeled with primes), portions of domain A are
shown in gray and portions of domain B are shown in silver. The
sulfate site for the second subunit is labeled sulfate 2. (b) Surface
representation showing the proposed binding sites for ATP and
FGAM. The N-terminal residues (starting at position 20) for subunits
2–4 are shown in magenta. The ordered N-terminal residues (starting
at position 5) for subunit 1 are shown in the transparent gray.
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duplication, it can potentially fold back upon itself to
form a monomer. 
Comparison of PurM with other ATP-dependent enzymes 
The PurM fold has not been previously observed, but
sequence alignments suggest that it may resemble several
other ATP-dependent enzymes whose structures are not
yet known. PSI-BLAST database searches with the E. coli
PurM protein sequence reveal similarities to several
hydrogenase maturation proteins (HypE), thiamine
monophosphate kinase (ThiL), selenophosphate syn-
thetase (SelD), and most interesting, FGAR amidotrans-
ferase (PurL). With the exception of PurL, all of these
enzymes are the same size as PurM (~340 amino acids).
Even though ThiL and SelD use ATP [29,30], their
chemistry must be mechanistically different [31] from that
postulated for PurM. The relationship between HypEs
[32], which are not known to be ATP-dependent
enzymes, and PurMs remains a mystery. We will thus
focus specifically on the similarities between the PurLs
and PurM. As noted in the introduction, PurL precedes
PurM in the purine biosynthetic pathway and seems to be
mechanistically similar. Importantly, additional enzymes
thought to function by similar catalytic mechanisms [33]
(CTP synthetase [34], 5-oxoprolinase [35]) were not
detected by these sequence searches.
PurL is the fourth enzyme in the purine pathway, generat-
ing the PurM substrate FGAM from FGAR (Figure 1).
PurL sequences can be divided into two classes: the large
PurLs have a glutaminase domain within a polypeptide of
~1450 amino acids, whereas the small PurLs (~740 amino
acids) have a separate glutaminase protein, PurQ (~230
amino acids). PurQ and small PurL FGAR amidotransferase
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Figure 6
Sequence alignment for PurMs from diverse
organisms. Locations of the secondary
structural elements are labeled above the
sequence. Conserved residues are highlighted
in red. The sequences shown are E. coli (Eco),
B. subtilis (Bsu), M. tuberculosis (Mtu),
Methanobacterium thermoautotrophicum (Mth),
Synechococcus sp. (Syn), Arabidopsis thaliana
(Ath), Saccharomyces cerevisiae (Sce),
Homo sapiens (Hsa) and Drosophila
melanogaster (Dme). The red arrow indicates
the position of K27, which is modified by FSBA,
and the pair of asterices indicates the site of
the PurM′ domain insertion in the Dme
sequence. Thirteen additional sequences from
mesophiles are not shown. Overall sequence
identity ranges from 38 to 55%.
1        10        20        30         40        50            60        
Eco MTDKTSLS KDA   IDA NAL GRIKGVVKKTRRP.EVMGGL   GA CALPQK.YR...EPVLVSG     T        Y   GVD   G   V                    GGF  L                   TDGVG 
Bsu ....MSEA KNA   IEA YEA KRMKKHVERTKRL.GVMGSL   GG FDLSELSYQ...KPVLISG     T        Y   GVD   G   V                    GGF  M                   TDGVG 
Mtu DPGSRGIT ASA   IEA DRA DLFKPLASKATRP.EVRGGL   AG FTLRG.DYR...EPVLAAS     T        Y   GVD   G   I                    GGF  L                   SDGVG 
Mth .....MVT SES   IDL ELT SSLTSRLSDTLKYCDVITGA   AA VRMG........DVAIAMS     S        Y   GVD   E   V                    GHF  L                   TDGVG 
Syn ......MD RQA   VEA REF SRIRQQVESTFRP.EVMGGI   AG FEIPAG.YK...APVLVSG     T        Y   GVD   G   V                    GGF  L                   TDGVG 
Ath DDDTDSLN KDS   IDA AEL KRIAKMAP..........GI   GG FPLG........DSYLVAG     T        Y   GVD   G   V                    GGF  L                   TDGVG 
Sce .SSKVAIT ADS   VDN NNL QTIKEMVRSTRRP.GADSDI   GG FDLAQAGFRQNEDTLLVGA     T        Y   GVS   G   V                    GGF  L                   TDGVG 
Hsa LQQPRSLT KES   IAA NML KKIQPLAKATSRS.GCKVDL   AG FDLKAAGFK...DPLLASG     T        Y   GVD   G   V                    GGF  L                   TDGVG 
Dme .ASTPGLS KDS   IDA DAL QRIKPLSRGTQRP.GVIGGL   GG FRLKELTYK...EPVIAEA     A        Y   GVD   G   V                    GGF  L                   TQGVG 
                                                                          
70        80        90       100       110       120       130       140  
Eco  LRL MDLKRHD I I LV  C   LVVQ  E LFF   Y TGKLDVDTASAVIS IAE  LQSGC  V     K   A       T G D  AM VND    GA P   LDY A              G   GC     SL GGETA
Bsu  LKL FSMDKHD I V AV  C   VLAQ  E LFF   L VGKADPVKIEQIVQ VAE  EQSGS  V     K   A       T G D  AM VND    GA P   LDY A              G   GC     AL GGETA
Mtu  LAI QAMDKHD V L LV  V   LVVC  E LFL   I VGRIVPERLSAIVA IAD  MRAGC  L     K   A       T G D  AM VDD    GA P   LDY A              G   GC     AL GGETA
Mth  ILV EMMNRYD V I CI  V   ILCV  R AAL   L VERPDPEVAGEIGK LAM  EMARV  I     K   A       T G D  AM VND    GA P   VDY A              G   GA     AI GGETA
Syn  LKI QAMDQHH I I LV  C   ILTT  E LYF   L TGKLEPAQLADVVT IVE  KQSGC  L     K   A       T G D  AM VND    GA P   LDY A              G   GC     AL GGETA
Ath  LKL FETGIHD I I LV  S   IITS  K LFF   F TSRLDVDLAEKVIK IVE  RQSEC  L     K   A       T G D  AM VND    GA P   LDY A              G   GC     AL GGETA
Sce  LII QETGIHN V I LV  N   LVVQ  E LFF   F TGALDIQVASDFVS VAN  IQSGC  V     K   A       T G D  AM VND    GA P   LDY A              G   GC     AL GGETS
Hsa  LKI QLCNKHD I Q LV  C   ILAQ  E LFF   F CGKLDLSVTEAVVA IAK  GKAGC  L     K   A       T G D  AM VND    GA P   LDY S              G   AC     AL GGETA
Dme  IHL LTHEFYE V Y LF  A   VLEV  E VAF   I CGKLQVPLAAQLVK MAD  RDARC  V     K   A       N G D  AL AND    GA P   LDY A              G   GC     AL GGETA
     150       160       170        180       190       200        210    
Eco  M GMYHGEDY VAGFC  VVEKSEIIDGSKVS.D  VLIALG   P    Y    KILEVSG.CDPQTTELD.E P        D     VG                GD      SSG HSNG SLVR                  
Bsu  M GLYTADEY IAGFS  VAEKDEIVTGEKIE.E  LLIGLS   L    F    KVLLDDA.AWDLDTTYEPE P        D     VG                GH      SSG HSNG SLVR                  
Mtu  H GLIEPDHY ISATG  VVEADNVLGPDRVK.P  VIIAMG   L    Y    KVLLEIDRMNLAGHVEEFE P        D     VG                GD      SSG HSNG SLVR                  
Mth  L GIIR..NL LAATG  FVDVDRIITGEDVS.P  TVIGLE   I    L    RVFFDELELSPEDEMPGSS P        D     IG                GD      SSG HSNG SLAR                  
Syn  M GFYGAGEY AAGFA  IVEKSQLLNGSQVN.I  VAIAVE   V    F    KIIESNG.WQWSDCLPEWE P        D     VG                GD      SSG HSNG SLVR                  
Ath  M DFYAEGEY LSGFA  IVKKTSVINGKNIV.A  VLIGLP   V    F    RVLARSN.LSLKDALPGGE P        D     VG                GD      SSG HSNG SLVR                  
Sce  M GMYPPGHY TNGTA  AVLRQDILPKINEMAA  VLLGLA   V    F    KIIQHVA.LPWDAPCPWDE P        D     VG                GD      SSG HSNG SLVR                  
Hsa  M DMYPPGEY LAGFA  AMERDQKLPHLERITE  VVVGIA   L    F    KIVAKSS.LQYSSPAPDGE P        D     VG                GD      SSG HSNG SLVR                  
Dme  M SLYAPGQH MAGYC  IVEHSRILPRFDLYQP  LLIGLP   L    F    AVLKRVG.LGLHDKAPFSE P        D     VG                GD      SSG HCAG SLVH                  
                                                                          
      220       230       240          250       260       270        280 
Eco ..GKP  DHLLA  R  VKSVLELIEKVD...VHAI  L    FWE IP VLPDNTQAVIDESSWQWPE.V NW     LA     PT IY                   AH TGGG   N  R                     F  
Bsu F.ERP  QELVE  R  VKPVLAAVKSGK...IDGM  V    FIE IP MLPEGLSAEIDHGSWPIPP.I SF     LG     PT IY                   AH TGGG   N  R                     F  
Mtu G..RT  EELLE  R  AKDCLALAAETR...VRTF  V    LAG LQ VIPHGLIAEVDRGTWTPAP.V TM     LG     PT IY                   CH TGGG   N  R                     F  
Mth ..SSS  DELLR  R  VEPIMELIESDVD..VHGL  I    FG. LK .LRKDVGYRLD..SLPEPQQI RV     VG     PT IY                   AH TGGG   N  R                     F  
Syn G.GQS  EIFLE  R  VKPIQALLKSGI..NIHGM  I    LPE LP CLGQGQSIQVKAGSWQPLP.V NW     LG     PT IY                   AH TGGG   N  R                     F  
Ath ..SST  DALMA  V  VKQVLDMIEKGG...VKGL  I    FTD IP VFPDGLGAVIHTDAWELPP.L KW     LG     PT IY                   AH TGGG   N  R                     F  
Sce E.SKT  EGILE  K  VKQLLPSIRQR..L.LLGL  I    LVE IP AIPDHLQARVDMSTWEVPR.V KW     LG     PT IY                   AH TGGG   N  R                     F  
Hsa CGDQT  DLLLT  R  SHSLLPVLRSG..H.VKAF  I    LLE IP VLPEKLGVDLDAQTWRIPR.V SW     LG     PT IY                   AH TGGG   N  R                     F  
Dme D..KT  EELLV  K  VKALSTLLSRGKHG.IKAL  I    LSE IP VLRKDLAVRLDANKFQLPP.V AW     LG     PT IY                   AH TGGG   N  R                     F  
                                                                          
      290       300       310       320       330          340            
Eco LQTA NVEHHEMYRTF C V MIIALPAPEVDKALALLNANGENAWKI IIKAS...DSEQRVVIE......      G           N G G                           G                       
Bsu LQEY KLKEEDMFNVF M I FVLAVKEEHLTDVIGTLESHGEKAYLI RVKKG...EGVTFGGAALS....      G           N G G                           G                       
Mtu IAQR RVRRTEMEKTF M V MIAVVAPEDTTRALAVLTARHLDCWVL TVCKG..GKQGPRAKLVGQHPRF      G           N G G                           G                       
Mth IHEA .VDIREMYRVF M V FCAVVAPDDVDEALSILGDR...AHPI EVTDR.GSEVELEACTGETIKL.      G           N G G                           G                       
Syn LADK QVNSTAMLETF L V FVVLVSPEQRQTTLDFFSGQGLVANQI TVIEG...DGAFVWLD.......      G           N G G                           G                       
Ath IQQT RIEDSEMRRTS P . .....DRD................GYG .......................      G           L G .                           G                       
Sce FGQA NVPHDDILRTF M V MVLIVKRENVKAVCDSLTEEGEIIWEL SLQER..PKDAPGCVIENGTKLY      G           N G G                           G                       
Hsa LQQE HLSEEEMARTF C V AVLVVSKEQTEQILRDIQQHKEEAWVI SVVAR..AEGSPRVKV.......      G           N G G                           G                       
Dme LAAA NISSTELQRTY C L MVLVVAPTEVEDVLKELR.YPQRAAVV EVVARKDPKKS.QVVV.......      G           N G G                           G                       
α1 β1  
α2 α3 β2  α4 β3  
β4  β5  α5 
α6 α7 β6  α8 β7  
α9 α10 β8 α11 β9  β10  
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forms are found in archaebacteria and several Gram-positive
bacteria (Bacillus subtilis, Mycobacterium tuberculosis, Lacto-
bacillus casei [36–38]), whereas large PurLs are found in
most other organisms [1,13]. There is a remarkably low
degree of sequence identity (6–7%) between the small and
large PurL classes, which have 16% and 15% sequence
identities within their respective groups. To date, only the
large PurLs have been biochemically characterized [13,39].
The A domain of all PurM sequences, whether PurM is
monomeric or part of a multifunctional protein, resembles
the small PurL family. No alignments to the large PurL
family, including the E. coli protein, are detected in BLAST
searches, although they do appear at low similarity levels in
the more sensitive iterated PSI-BLAST searches. 
Sequence alignments using CLUSTALW [40] were
carried out between the PurMs and small PurLs, exclud-
ing all of the hyperthermophiles. The A domain of PurM
aligns with a 100 amino acid residue region at the N ter-
minus of the small PurLs (residues 70–170). The con-
served residues are not extensive and both deletions and
insertions are required to make these alignments.
However, the structure of PurM provides a guide to
thinking about these alignments and their significance.
First, the alignments reveal that eight glycine residues are
conserved in strategic positions: there is a conserved
glycine in the flexible glycine-rich loop of PurM (residues
40–43), and there are numerous glycine residues in the
regions of putative metal-binding ligands located in the
active-site cleft of PurM. Glycine residues are common at
the active sites of proteins, where they confer sufficient
flexibility for proper functioning of catalytic regions [41].
The most convincing regions of homology reside in a
sequence D94x4GAxP102 (E. coli PurM numbering;
residues 121–130 in B. subtilis PurL). This region is con-
served among all the PurMs and small PurLs and includes
D94, which may be a ligand to Mg2+ATP. A second region
of limited, but significant, homology is G125x13(G/A)GE141
(residues 157–173 in B. subtilis PurL). E141 may also be a
ligand to a metal in the ATP-binding site. Examination of
the structure of PurM (Figure 5) reveals that both D94 and
E141 are present in the putative active-site cleft. Also clear
in the figure is that these aspartate and glutamate residues
are on separate subunits. Thus this alignment makes a
clear prediction: if PurLs are structurally homologous to
PurMs, the small PurLs must function as dimers to form
their ATP-binding sites, unless a single subunit of PurL is
able to fold back upon itself. 
Limited homology and alignment by metal ion binding
motifs has recently been used to identify the enolase super-
family of enzymes, which catalyze reactions involving car-
banion intermediates [42]. Once one knows where to look,
based on the structure and chemistry, one can find other
members of a superfamily [43]. In the case of PurM and
PurL, we need a structure of a nucleotide-bound PurM and
the structure of a small PurL to confirm this speculation.
Possible structure of trifunctional GARS–PurM–GART 
One intriguing aspect of the purine biosynthetic pathway is
that multifunctional enzyme fusions are common in higher
organisms and rare in bacteria [1]. PurM is the central com-
ponent of the vertebrate trifunctional PurD–PurM–PurN
[17] and the fly PurD–PurM–PurM′–PurN [44] fusions
(Figure 2). As all three prokaryotic forms of these highly
conserved enzymes are now crystallographically character-
ized [2,20], it is possible to use sequence alignments to esti-
mate the lengths of the two linkers that separate the
enzyme modules, and to model the trifunctional enzyme
based on the shapes of its individual components. 
Using sequence alignments, the PurD–PurM and the
PurM–PurN linker lengths have been estimated to arrive
at a model for the trifunctional protein (Figure 7). Using
sequence alignments and the structures of E. coli PurD and
PurM, we estimate the linker length may be as short as two
to seven residues between PurD and PurM. Similarly, the
linker length between PurM and PurN is estimated to be
in the range of 17–28 residues. The linker sequences
suggest that they are positively charged at neutral pH.
The crystallographically visible N-terminal residues of
PurM contact the B domain of the partner subunit
(Figure 5b). Thus, the results of the linker analysis predict
that in the trifunctional protein the PurD domain is in inti-
mate contact with the B domain of the other subunit in
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Figure 7
Model of the trifunctional enzyme of mammalian purine biosynthesis
(PurD–PurM–PurN) composed from structures of the E. coli
homologs. PurD (red) is unliganded (PDB identifier 1gso [2]), PurM
(blue, subunit 1 and light blue, subunit 2) is bound to sulfate, and PurN
(green) is bound to GAR and a folate analog (PDB identifier 1cde
[20]). Note the head-to-tail arrangement of the dimer and the proximity
of the PurD and PurN domains. Linkers between domains are shown
as bars, colored black for the subunit 1 fusion and light blue for the
subunit 2 fusion. The dimensions of the model are 200 × 100 × 85 Å.
~25
Amino
acids
2–5
Amino
acids
PurDA
PurMA
PurNA
PurNB PurMB
PurDB
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the PurM dimer, to which the PurN domain is covalently
fused by a longer tether. Thus, the PurM B domain will
contact both fused enzymes. It is further evident that
PurD and PurN, catalyzing steps 2 and 3 in the purine
biosynthetic pathway, are constrained to be within
20–30 Å of each other, raising the possibility that the
product of PurD, GAR, may be transferred directly, or
channeled, between the active sites of these domains of
the trifunctional enzyme. 
The elongated conformation of the vertebrate trifunc-
tional protein depicted in Figure 7 would also explain the
anomalously large apparent molecular weight reported for
the avian forms of the enzyme. Sucrose-gradient ultracen-
trifugation and size-exclusion chromatography using glob-
ular proteins as molecular-weight standards [13] allowed
calculation of a solution size of 330 kDa for the trifunc-
tional enzyme, an apparent trimer of the 108 kDa gene
sequence [45,46]. Our prediction from the PurM structure
is that this protein is really a dimer. Using the crystal-
structure coordinates, we calculated radii of gyration for
the PurM dimer (34 Å) and the trifunctional model in
Figure 7 (~60 Å). These radii indicate that the trifunc-
tional protein is roughly five times larger than the 70 kDa
PurM dimer, in qualitative agreement with the observed
trifunctional protein molecular weight.
Biological implications
The first crystal structure of an AIR synthetase, which
is also the first member of a distinct class of ATP-utiliz-
ing enzymes, reveals that the dimer is the minimal struc-
tural and functional unit. It completes the structure
determination of all three components of the human tri-
functional enzyme (PurD–PurM–PurN) of purine
biosynthesis, an emerging chemotherapeutic target.
Recent studies have suggested that a pyrrolo
[2,3-d]pyrimidine folate analog inhibits a variety of
human folate-requiring enzymes, including PurN and
PurH [19]. The success of an agent that inhibits multiple
folate-requiring enzymes in the purine pathway suggests
that the purine pathway should be revisited as a thera-
peutic target. Perhaps PurM and PurD inhibitors in
combination with other nucleic acid synthesis inhibitors
could function as anti-tumor agents. The structure of
PurM is a starting point for designing inhibitors of this
interesting reaction.
The structure of PurM and sequence alignments with
PurL suggest that enzymes 4 and 5 in the purine
pathway, which share a common product/substrate, will
also share a common ATP-binding structural motif.
Furthermore, identification of a number of additional
enzymes that utilize Mg2+ATP with this proposed motif,
through their conserved glycines and metal ion binding
residues, suggests that we have uncovered a new super-
family of ATP binders.
Materials and methods
Protein expression and isolation
The N-terminal (His)6-tagged PurM overexpression vector (pHAS)
was prepared by cloning a polymerase chain reaction (PCR) product
derived from the wild-type E. coli PurMN expression plasmid pJS119
[15] into the EcoRI–HindIII sites of a modified pET28 vector [47].
The oligonucleotide primers used for PCR were 5′-CCGAATTCGT-
GACCGATAAAACCTCTCT and 5′-CAAAAGCTTTTATTCGATAAC-
CACGCGTTGTT, where the EcoRI or HindIII sites are underlined.
FGAM was prepared and quantitated as described previously [12,16].
The (His)6-tagged PurM was quantitated using the Bradford assay and
crystalline bovine serum albumin as a standard [48]. PurM activity was
monitored using the Bratton–Marshall assay for diazotizable amines
[12,49]. A typical reaction mixture in a final volume of 1 ml contained
50 mM HEPES (pH 7.5), 20 mM MgCl2, 150 mM KCl, 0.1 mM β-FGAM,
2 mM ATP and was carried out at 37°C. The reaction was initiated with
1.1 µg of protein and 0.15 ml aliquots were quenched at various times
with 20% trichloroacetic acid in 1.33 M potassium phosphate (pH 1.4).
One unit (U) is defined as one µmol AIR formed per min. 
BL21(DE3) cells transformed with pHAS were selected on LB plates
with 70 mg/l kanamycin. A single colony was transferred into 1.2 l LB
with kanamycin and grown with shaking at 37°C to an A600 ≈ 1, at
which time solid isopropyl-β-D-thiogalactoside (Boehringer Mannheim)
was added to 0.3 mM. After growth for an additional 3 h at 37°C, the
cells (6 g) were harvested by centrifugation at 4°C at 5000 × g for
10 min. A 9% sodium dodecyl sulfate polyacrylamide gel electrophore-
sis gel showed induction of a 38 kDa band that accounted for 60% of
the total protein (data not shown). Cells were resuspended in 60 ml
buffer (0.1 M KCl, 20 mM Tris, pH 8.0, in 10% glycerol) and disrupted
by two passes through a French press at 16,000 psi. Cell debris was
removed by centrifugation at 4°C at 24,000 × g for 45 min. Iminodi-
acetic acid 6B FF resin (Sigma, 5 ml) was charged with 0.1 M NiSO4 in
water (10 ml), washed with water, and equilibrated in buffer. A slurry of
the charged resin was poured into the soluble extract, which was
stirred at 4°C for 30 min. The resin was centrifuged at 4°C at
10,000 × g for 10 min, the supernatant was decanted, and the resin
was poured into a glass column (1.5 × 3.0 cm). The column was
washed with buffer (30 ml) and buffer plus 10 mM imidazole (50 ml).
Bound proteins were eluted with buffer plus 400 mM imidazole (50 ml);
EDTA and βME were added from concentrated stocks to the pooled
eluate to final concentrations of 10 mM. The eluate was concentrated
by ultrafiltration (Amicon YM30 membrane) to 5 ml, which was dialyzed
overnight against buffer plus 10 mM βME (1 l, two changes) at 4°C.
The dialyzed enzyme was concentrated by ultrafiltration, flash-frozen in
aliquots in liquid N2, and stored at –80°C.
(His)6-tagged PurM (0.1 mg in 0.1 ml of 0.2 M KCl, 50 mM Tris, pH 8.0)
was injected onto a BioRad BioSilect SEC 250-5 column
(7.8 × 300 mm) equilibrated in and eluted isocratically with the same
buffer at 23°C at 0.75 ml/min. A mixture of molecular-weight standards
(thyroglobulin [669 kDa], immunoglobulin G [158 kDa], ovalbumin
[44 kDa], myoglobin [17 kDa], and vitamin B12 [1.35 kDa] from
BioRad) was injected and eluted from the same column under the same
conditions. The elution times were used to construct a calibration curve.
PurM containing SeMet was prepared using the same cell growth and
protein-purification procedure described for PurD containing SeMet [47],
in which pHAS was substituted for the PurD overexpression construct.
Crystallization
Crystals of SeMet PurM were prepared by the hanging-drop vapor-dif-
fusion technique. The SeMet (His)6-tagged PurM was stored at a con-
centration of 12 mg/ml in 15 mM Tris at pH 7.5, with 10 mM DTT to
protect the SeMet (His)6-tagged PurM from oxidation. The protein
solution was stored at –70.0°C and a freshly thawed sample was
used for all crystallizations. Optimized crystallization conditions con-
sisted of 2.10–2.25 M ammonium sulfate and 3–6% (v/v) isopropanol.
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No additional buffer was added. The hanging drops consisted of 3 µl
of protein solution plus 3 µl of well solution and were equilibrated
against 1 ml of well solution. Crystals appeared after 7 days and grew
to a maximum size of 0.1 × 0.1 × 0.5 mm in 10–14 days. Crystals of
SeMet (His)6-tagged PurM belong to space group P212121 with unit-
cell dimensions of a = 71.2 Å, b = 211.7 Å and c = 94.4 Å. The
Matthew’s number is 2.38 Å3/Da, assuming four molecules per asym-
metric unit, which corresponds to 47.5% solvent volume. 
X-ray data collection
The MAD data were collected at CHESS station F2. The data-collection
crystal was flash-frozen in a liquid N2 stream at 170K. The stabilizing
solution contained 25% (v/v) glycerol to prevent crystal damage during
freezing. All data were recorded with a Quantum 4 mosaic charge-
coupled device (CCD) detector. A crystal scan was used to determine
the wavelengths for data collection. Data were collected at the Se
absorption edge (12.661 keV), the absorption peak (12.664 keV) and at
a remote reference energy (12.864 keV). The crystals showed a low
mosaic spread (0.200°) and 2.5 Å data could be measured using a 2.0°
oscillation angle and an exposure time of 40 s. A total of 66.0° of data
were collected plus inverse beam images for each of the three energies.
The data were processed with MOSLFM [50] and scaled using SCALA
[51]. Because of technical problems during data collection, only the fully
recorded reflections were used, resulting in a completeness of about
91% and a redundancy of greater than four. The Rsym values for the
edge, peak and remote energies were 5.4%, 5.6% and 4.7%, respec-
tively. Data-collection statistics are summarized in Table 1.
Structure determination
Integrated intensities were processed using the programs DREAR and
DIFFE to calculate normalized structure factors, E, from the anomalous
differences [52]. The 3.0 Å data from the peak absorption were input
into the direct methods program SnB [53], which implements the
Shake-and-Bake procedure of Hauptman and coworkers [54]. The
Shake-and-Bake procedure uses the minimal principle and real-space
filtering to refine randomly generated phase angles for the largest
E values. A total of 500 random trials were used with 1120 E values
and 11,200 triple phase relationships. For each trial, the phases were
refined through 150 cycles of the Shake-and-Bake procedure. The
results for the 500 trials showed a bimodal distribution of the minimal
function and indicated that three of the random trials had converged to
the correct phase angles. Each of the three phase sets consistently
showed 23 of the 28 possible Se-atom sites. Technical problems
during data collection limited the data quality and may be the reason
that five Se-atom sites were not found by SnB.
The Se sites were refined and phases calculated with the program
MLPHARE [55]. At 3.0 Å, the overall figure of merit (FOM) was 0.568.
The maps calculated directly from unmodified MLPHARE phases
showed a clear protein/solvent boundary, including the major protein
domains and many secondary structure features. However, the electron
density contained many breaks and the mainchain tracing was not pos-
sible at this stage. The electron density was then modified by noncrys-
tallographic-symmetry (NCS) averaging using the four monomers in
one asymmetric unit. The transformation matrices between monomers
were estimated using the corresponding Se atoms in each of the
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Table 1
X-ray data-collection statistics.
Dataset Edge Peak Remote
Wavelength (Å) 0.9792 0.9790 0.9638
Resolution (Å) 20–2.5 20–2.5 20–2.5
Unique reflections 45,728 45,754 45,650
Redundancy 4.2 4.2 4.2
Completeness(%) 91.4 91.4 91.4
I/σ ratio 10.1 8.8 9.7
Rsym (%) 5.4 5.6 4.7
Rsym (2.64–2.50 Å; %) 18.3 19.9 14.3
Figure 8
Stereoview of a section of electron density
corresponding to an α-helical region of the
model. The MAD-phased electron-density
map has been modified by solvent flattening
and fourfold-symmetry averaging. The electron
density is contoured at 1σ.
 Ile83 
 Asn93 
 Ile83 
 Asn93 
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monomers and refined by the program RAVE_IMP [56]. The NCS aver-
aging, solvent flattening and histogram matching were performed with
the program DM [57]. Solvent flattening and histogram matching alone
resulted in a drop in the DM R factor from 51.6% to 43.7%. NCS aver-
aging improved the phases further and the DM R factor indicator
dropped to 35.8%. Using this procedure, the maps at both 3.0 Å and
2.5 Å became traceable. Figure 8 depicts a section of α helix in an
initial Fo map at 3.0 Å resolution.
The first round of chain tracing allowed the fitting of 291 out of 345
residues, leaving 20 residues at the N terminus, residues 40–55 and
residues 203–216 not built for all four monomers. The N terminus con-
tained the polyhistidine tag that was used for purification. The initial
crystallographic R factor based on this model was 44.2%. The first
round of refinement was carried out with strict NCS constraints and
resulted in an R factor of 31.5% (Rfree 33.6%) at 2.5 Å resolution.
Residues 203–216 were added to the model in a second round of
model building. For the second round of refinement, the NCS restraints
were relaxed, which resulted in a R factor 27.0% and Rfree 31.0%.
Residues 47–55 were added to the model for each monomer. In paral-
lel, torsion-angle refinements were performed using CNS [58], yielding
almost the same results. At this point, the N-terminal 20 residues and a
glycine-rich loop, 40–46 (GGLGGFG), were missing from the model.
Subsequently, refinements without NCS restraints helped build
residues 40–46, which showed conformational variations among the
four monomers. The N-terminal residues, 5–20, were visible only in one
monomer. In the final stages of refinement, 538 water molecules were
included. In addition, a sulfate ion was located at the same position in
each of the four monomers. The final refinement statistics are summa-
rized in Table 2. The final R factor was 19.2% (Rfree 26.4%). The final
Ramachandran plot [59] showed good geometry for the final model,
with 90.1% of the residues in the most favored region.
Prediction of the molecular weight of the trifunctional
(PurD–PurM–PurN) fusion protein based on individual
structures and the model for the fusion protein structure
The radii of gyration for monomeric PurD (22 Å), dimeric PurM (34 Å) and
monomeric PurN (17 Å) were calculated using MOLEMAN2 (GJ Kley-
wegt, unpublished program) on all non-water atoms in each PDB file
(PurD, 1gso.pdb [2]; PurN, 1cde.pdb [20]). A model of the trifunctional
protein shown in Figure 7 has a radius of gyration of ~60 Å, indicating
that it is roughly (60/34)3 = 5.4-fold larger than the PurM dimer or about
380 kDa. The PurM dimer has been used to compare size because it has
an elongated shape, similar to that proposed for our trifunctional model.
Figure generation
Programs used to prepare figures included MolScript [60], GRASP
[61], Raster3D [62], and ESPript (P Gouet, unpublished program).
Accession numbers
The coordinates for the PurM model have been deposited with the
Protein Data Bank with accession code 1CLI.
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